Abstract:
A comprehensive examination of 46 children aged 7 to 15 years old, who were hospitalized in the pediatric nephrology department of the TMA clinic (Tashkent medical academy) with a nephrotic form of chronic glomerulonephritis, was carried out. Of these, 22 children (group 1) received traditional therapy, 24 children (group 2) received dipyridamole at a dose of 3–4 mg/kg, 2 times a day as antiplatelet therapy. Indicators of platelet aggregation activity were studied on a “Chronolog–140” aggregometer (USA) in the biochemical laboratory of the RSCC (Republican Specialized Center for Cardiology) before treatment and after two weeks of dipyridamole therapy. The digital material was processed by the method of variation statistics.
